Low molecular haptens are import causes of occupational and other forms
of asthma. They are presumed to mediate their effects via inflammatory
and immune mechanisms. The pathogenetic events that mediate
inflammation and functional dysregulation in hapten sensitized and
exposed individuals, however, are poorly defined. To address these
events we have established a model of hapten asthma using
picrylchloride. In this model, appropriately sensitized and challenged
mice develop late phase increases in airways resistance and nearly 100-
fold increases in airway reactivity. This reactivity can be adoptively
transferred to naive mice by antigen-specific populations of lymphocytes
and is associated with submucosal infiltration by T cells, mononuclear
cells and neutrophils. We believe that this inflammatory process
mediates the functional changes that we have seen. We hypothesize that
these inflammatory cells produce specific cytokines which induce the
expression of a specific pattern of endothelial adhesion molecules which
allows for the recruitment of inflammatory cells that mediate airway
dysfunction. We propose to:
1) Characterize the inflammatory process that develops in the airway
following antigen challenge and/or direct cell transfer. We will
characterize the inflammatory response, the time course and location of
cytokine gene expression by infiltrating and intrinsic lung cells, the
pattern of endothelial adhesion molecule expression and the development
of airways hyperresponsiveness (AHR).
2) Selectively interfere with the local recruitment of specific
inflammatory cells to the airway by influencing cytokine responses
and/or endothelial adhesion molecule expression and examine the effects
of these manipulations on the development of inflammation and AHR. We
will do this using cytokine receptor knock-out mice, bone marrow
chimeric mice reconstituted with either wild-type or receptor deficient
donor cells and mice treated with antibodies against P-selectin or a
small molecule inhibitor to VCAM-1.
3) Compare the patterns and locations of cytokine adhesion molecule
expression in the mouse hapten model to biopsies from human hapten-
induced isocyanate asthma. The pattern and location of cytokine and
adhesion molecule expression in the murine model and human tissues will
be compared.
The analysis of this unique model which recapitulates in mice many of
the features of human asthma will allow a more precise definition of the
cellular interactions leading to the development of hapten-induced
asthmatic airway hyperreactivity.
No Sub Projects information available for 1P50HL056389-01 0005
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1P50HL056389-01 0005
Patents
No Patents information available for 1P50HL056389-01 0005
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1P50HL056389-01 0005
Clinical Studies
No Clinical Studies information available for 1P50HL056389-01 0005
News and More
Related News Releases
No news release information available for 1P50HL056389-01 0005
History
No Historical information available for 1P50HL056389-01 0005
Similar Projects
No Similar Projects information available for 1P50HL056389-01 0005